BBIO: BridgeBio Pharma, Inc. Common Stock Company Profile & Statistics

BridgeBio Pharma, Inc. Common Stock Profile

About

BridgeBio Pharma Inc. is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio Pharma Inc. is based in PALO ALTO, Calif.

Info & Links

CEO

Neil Kumar

Headquarters

3160 PORTER DR., SUITE 250
PALO ALTO, CA 94304, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

730

BridgeBio Pharma, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

14.80B

Enterprise Value

16.01B

Enterprise Value/EBITDA(ttm)

-26.48

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

42.21

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

88.39%

Operating Margin(ttm)

-220.60%

Profit Margin(ttm)

-1241.40%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-181.21%

Return on Assets(ttm)

-80.47%

Income Statement

Revenue(ttm)

353.78M

Revenue Per Share(ttm)

1.84

Gross Profit(ttm)

338.84M

EBITDA(ttm)³

-604.51M

Net Income Available to Common(ttm)

-797.12M

Diluted EPS(ttm)

-4.18

Share Statistics

Beta (5Y Monthly)

1.17

52-Week Change

111.86%

S&P 500 52-Week Change

14.04%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

192.71M

Dividend Yield

0.00%

Float⁴

157.64M

% Held by Insiders

18.20%

% Held by Institutions

99.85%

Balance Sheet

Total Cash(mrq)

645.94M

Total Cash Per Share(mrq)

3.35

Total Debt(mrq)

1.85B

Total Debt/Equity(mrq)

-96.27%

Current Ratio(mrq)

3.88%

Quick Ratio(mrq)

3.76%

Book Value Per Share(mrq)

-9.98

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.03

Free Cash Flow(ytd)

-390.55M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BBIO

BridgeBio Pharma, Inc. Common Stock